According to the American Cancer Society, more than 7,000 New Jersey men will be diagnosed with prostate cancer this year. The appropriate treatment option can vary greatly depending on a number of factors including the stage, grade of the tumor, age, health and lifestyle of the patient.
New Jersey CyberKnife treats prostate cancer with stereotactic body radiation therapy using advanced CyberKnife® technology. The procedure is noninvasive and requires no sedation or incision. Patients are treated within five outpatient treatment sessions, resulting in minimal disruption to daily routines and overall quality of life. For more information on prostate cancer treatment options, view the info-graphic below.
This is not intended as medical advice to replace the expertise and judgment of your health care team. It is intended to help you and your family make informed decisions, together with your doctor.